These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9192063)

  • 1. Innovations in topical therapy.
    Richter F; Scheppach W
    Baillieres Clin Gastroenterol; 1997 Mar; 11(1):97-109. PubMed ID: 9192063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A practical guide to the management of distal ulcerative colitis.
    Ardizzone S; Bianchi Porro G
    Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The topical treatment of distal ulcerative colitis.
    Ardizzone S; Bianchi Porro G
    Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):599-602. PubMed ID: 8823577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How important is onset of action in ulcerative colitis therapy?
    Masson S; Nylander D; Mansfield JC
    Drugs; 2005; 65(15):2069-83. PubMed ID: 16225364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: aminosalicylates in inflammatory bowel disease.
    Hanauer SB
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():60-5. PubMed ID: 15352896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The local therapy of distal colitis and ulcerative proctitis].
    Scheppach W
    Dtsch Med Wochenschr; 1993 May; 118(20):751-4. PubMed ID: 8099006
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis.
    Lémann M; Galian A; Rutgeerts P; Van Heuverzwijn R; Cortot A; Viteau JM; Elewaut A; Belaiche J; Froguel E; Modigliani R
    Aliment Pharmacol Ther; 1995 Oct; 9(5):557-62. PubMed ID: 8580278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent therapy with high-dose 5-aminosalicylic acid enemas maintains remission in ulcerative proctitis and proctosigmoiditis.
    Mantzaris GJ; Hatzis A; Petraki K; Spiliadi C; Triantaphyllou G
    Dis Colon Rectum; 1994 Jan; 37(1):58-62. PubMed ID: 8287749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: problematic proctitis and distal colitis.
    Gionchetti P; Rizzello F; Morselli C; Campieri M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():93-6. PubMed ID: 15352902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis.
    Lee FI; Jewell DP; Mani V; Keighley MR; Kingston RD; Record CO; Grace RH; Daniels S; Patterson J; Smith K
    Gut; 1996 Feb; 38(2):229-33. PubMed ID: 8801202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical salicylate therapy (4-ASA and 5-ASA enemas).
    Ginsberg AL
    Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-ASA enema therapy.
    Hanauer SB
    Neth J Med; 1989 Jun; 35 Suppl 1():S11-20. PubMed ID: 2702307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas.
    Barber GB; Lee DE; Antonioli DA; Peppercorn MA
    Am J Gastroenterol; 1985 Aug; 80(8):612-4. PubMed ID: 2862789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mesalazine enema for ulcerative colitis.
    Drug Ther Bull; 1994 May; 32(5):38-9. PubMed ID: 7635028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
    Hanauer SB; Stathopoulos G
    Drug Saf; 1991; 6(3):192-219. PubMed ID: 1676590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enema therapy for ulcerative colitis patients].
    Furuta R; Kusugami K; Goto H
    Nihon Rinsho; 2005 May; 63(5):845-9. PubMed ID: 15881180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic efficacy of 5-ASA molecules in idiopathic intestinal inflammatory diseases: critical review].
    Van Gossum A
    Acta Gastroenterol Belg; 1992; 55(5-6):462-71. PubMed ID: 1363167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of distal ulcerative colitis: frequently asked questions analysis.
    James SL; Irving PM; Gearry RB; Gibson PR
    Intern Med J; 2008 Feb; 38(2):114-9. PubMed ID: 18290827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications.
    Schroeder KW
    Scand J Gastroenterol Suppl; 2002; (236):42-7. PubMed ID: 12408503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.
    Tursi A; Brandimarte G; Giorgetti GM; Forti G; Modeo ME; Gigliobianco A
    Med Sci Monit; 2004 Nov; 10(11):PI126-31. PubMed ID: 15507864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.